Mell L.K., I. Sirak and L. Wei, et al., 2017. Bone marrow-sparing intensity modulated radiation therapy with concurrent cisplatin for stage IB-IVA cervical cancer: an International Multicenter Phase II Clinical Trial (INTERTECC-2) . 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Int J Radiat Oncol Biol Phys., 97: 1-10.
Small, W., K. Winter, C. Levenback, R. Iyer and S.R. Hymes et al., 2011. Extended-Field Irradiation and Intracavitary Brachytherapy Combined With Cisplatin and Amifostine for Cervical Cancer With Positive Para-Aortic or High Common Iliac Lymph Nodes: results of arm II of Radiation Therapy Oncology Group (RTOG). 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Int. J. Gynecological Cancer, 21: 1-10.
Grigsby, P.W., K. Heydon, D.G. Mutch, R.Y. Kim and P. Eifel, 2001. Long-term follow-up of RTOG 92-10: Cervical cancer with positive para-aortic lymph nodes. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Int. J. Radiat. Oncol.*Biol.*Phys., 51: 1-10.
Rajamanickam, K., S. Sastri, U.M. Mahantshetty, T. Dora and N. Bharadwaj et al., 2017. Prospective Validation of Dose Volume Constraints for Acute Gastrointestinal Toxicity in Patients Undergoing Adjuvant IMRT for Cervical Cancer. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Int. J. Radiat. Oncol.*Biol.*Phys., 99: 1-10.
Chung, Y.L., J.J.M. Jian, S.H. Cheng, C.I. Hsieh and T.D. Tan et al., 2005. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: A phase I/II study. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Gynecologic Oncol., 97: 1-10.
Gerszten, K., K. Colonello, D.E. Heron, R.J. Lalonde and I.D. Fitian et al., 2006. Feasibility of concurrent cisplatin and extended field radiation therapy (EFRT) using intensity-modulated radiotherapy (IMRT) for carcinoma of the cervix. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Gynecologic Oncol., 102: 1-10.
Du, X.L., X.G. Sheng, T. Jiang, H. Yu and Y.F. Yan et al., 2010. Intensity-modulated Radiation Therapy Versus Para-aortic Field Radiotherapy to Treat Para-aortic Lymph Node Metastasis in Cervical Cancer: Prospective Study. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Croatian Med. J., 51: 1-10.
Jensen, L.G., M.D. Hasselle, B.S. Rose, S.K. Nath and Y. Hasan et al., 2013. Outcomes for Patients With Cervical Cancer Treated With Extended-Field Intensity-Modulated Radiation Therapy and Concurrent Cisplatin. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Int. J. Gynecological Cancer, 23: 1-10.
Vargo, J.A., H. Kim, S. Choi, P. Sukumvanich and A.B. Olawaiye et al., 2014. Extended Field Intensity Modulated Radiation Therapy With Concomitant Boost for Lymph Node–Positive Cervical Cancer: Analysis of Regional Control and Recurrence Patterns in the Positron Emission Tomography/Computed Tomography Era. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Int. J. Radiat. Oncol.*Biol.*Phys., 90: 1-10.
Zhang, G., F. He, C. Fu, Y. Zhang, Q. Yang, J. Wang and Y. Cheng, 2014. Definitive extended field intensity-modulated radiotherapy and concurrent cisplatin chemosensitization in the treatment of IB2-IIIB cervical cancer. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, J. Gynecologic Oncol., 25: 1-10.
LIU, Y., J. YU, L. QIAN, H. ZHANG and J. MA, 2016. Extended field intensity-modulated radiotherapy plus concurrent nedaplatin treatment in cervical cancer. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Oncol. Lett., 11: 1-10.
Grigsby, P.W., B.A. Siegel and F. Dehdashti, 2001. Lymph Node Staging by Positron Emission Tomography in Patients With Carcinoma of the Cervix. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, J. Clin. Oncol., 19: 1-10.